MAPT and tauopathy: Finally, in an ex vivo tauopathy model, we show that chronic P2X7R blockade markedly reduces pathological tau inclusions without significantly affecting soluble tau phosphorylation or tau localisation at synapses, suggesting the possibility of P2X7R involvement in the non-cell autonomous clearance of tau aggregates by glia.